Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Alzheimer’s Disease | Definition, Causes, Diagnosis & Treatment

Alzheimer’s Disease (AD) is the most common form of dementia worldwide (60-70% of all dementia cases) and is a progressive neurodegenerative disorder.

Alzheimer's Disease Questions

Coconut Oil and Dementia

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

Is Alzheimer's Disease Transmissible?

Does Depression and Anxiety Increase the Risk of Dementia?

AAM - The Search for a Cure to Alzheimer's

Dementia Treatment

Antidepressants and Dementia: Is There a Link?

AAM - Air pollution and Alzheimer's

Transcutaneous Electrical Nerve Stimulation for Dementia

Inflammation and Alzheimer's Disease

See more featured articles »

Can Happiness Protect You from Dementia?

Diet and Alzheimer's Disease

Alzheimer’s Disease and Calcium Supplements

Childhood Dementia Signs and Symptoms

What is Mixed Dementia?

Alzheimer's Disease Diagnosis

Alzheimer’s Disease and Gingko Biloba

Antibody Research and Alzheimer’s Disease

Mythbusting: Misconceptions in Dementia

Mixed Dementia Prevention and Treatment

Integrated PET/MR for Alzheimer’s Disease

Dementia with Lewy Bodies

Does Herpesvirus Cause Alzheimer's?

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Childhood Dementia Causes

Can Statins Protect Against Alzheimer’s Disease?

Dementia Diagnosis

Stress and Alzheimer's Disease

Mixed Dementia Symptoms and Diagnosis

Alzheimer's Disease Epidemiology

Migraines and Dementia

Alzheimer's Disease and the Microbiome

What is Dementia?

Alzheimer's Disease Symptoms

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Alzheimer's Disease Causes

Omega-3 and Alzheimer’s Disease

Dementia Symptoms

Alzheimer's Disease Prevention

Amyloid Cascade Hypothesis

Alzheimer's Disease and Sleep Disruption

Alzheimer's Disease Treatments

Dancing Through Dementia: How Movement Aids Memory and Mood

Alzheimer's and Veganism

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Stem Cell Therapy for Alzheimer's

Bright Light Therapy and Dementia

AAM - Genetics of Alzheimer's

What Causes Dementia?

Differences Between Alzheimer's and Dementia

Aromatherapy for Dementia

Designing Dementia-Friendly Environments

Gender and Alzheimer’s Risk

Types of Alzheimer's Disease

Alzheimer’s tangles and plaques: what’s the difference?

Pollution and Alzheimer's

What are Amyloid Plaques?

Biomarkers for Alzheimer's Disease

Dementia Prevention

Latest Alzheimer's & Dementia News and Research

TRIMTECH Therapeutics brings total seed round to $47 M with additional investment of $14 M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio

TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has raised an additional $14 million in seed funding, bringing the total for the round to $47 million (£35 million).

From TRIMTECH Therapeutics 23 Jun 2026

Psychological traits may uncover why Alzheimer’s biology differs between patients

In 822 deceased older adults from ROS and MAP, researchers linked stable psychological traits to multi-omic molecular subtypes of Alzheimer’s dementia using postmortem brain tissue from the dorsolateral prefrontal cortex. Neuroticism and loneliness were associated with molecular progression, while purpose in life showed subtype-specific inverse associations, suggesting psychological traits may align with Alzheimer’s biology beyond conventional neuropathology.

22 Jun 2026

Engineered CAR-T cells offer potential rheumatoid arthritis cure

For the 18 million people living with rheumatoid arthritis, disease management currently means a lifetime of injections-a reality that new research from Tsinghua University may soon begin to change.

22 Jun 2026

Study links genes and sleep habits to Alzheimer's risk

New research from Edith Cowan University (ECU) has discovered an important link between our genes and sleep habits, suggesting they work together to influence early brain and cognitive changes associated with Alzheimer's Disease, long before symptoms appear.

22 Jun 2026

AI discovers hidden antibiotic candidates inside disease-causing prions

New antibiotic candidates for drug-resistant bacteria may reside inside prions, mis-folded protein in the brain best known for rare and fatal degenerative brain diseases.

19 Jun 2026

Poll reveals gaps in brain health awareness among older adults

Nearly all Michiganders age 50 and over say it's very important to keep their brains healthy as they grow older, a new poll finds.

18 Jun 2026

Neurological disorders may raise traumatic brain injury risk in older adults

For traumatic brain injury (TBI) and certain brain diseases, it looks like the risk may go in both directions, according to a study published on June 17, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

17 Jun 2026

First human trial targets aging immune cells for healthier immunity

A first-in-human clinical trial of an immune rejuvenation therapy designed to restore the function of worn-out T cells is expected to begin later this year, building on research led by UCL scientists into the mechanisms of immune aging.

17 Jun 2026

Key Alzheimer's protein actively protects neurons from nuclear damage

Researchers at Niigata University's Brain Research Institute have uncovered a new function of amyloid precursor protein (APP), a molecule long studied as the precursor to amyloid-β (Aβ) in Alzheimer's disease (AD).

17 Jun 2026

USC study reveals nuanced Alzheimer's genetic risk in Hispanic populations

Researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC analyzed brain imaging and clinical data from more than 17,000 participants across five major aging and Alzheimer's disease studies.

17 Jun 2026

Blood proteins reveal which aging cells may raise disease risk

...

16 Jun 2026

Retinal photographs may reveal early Alzheimer's disease risk

Often called "the window to the soul," the eyes may also offer clues about something less poetic but just as important: the health of the brain.

16 Jun 2026

Loneliness linked to faster mental and physical decline in older adults

Some people might not mind spending time alone, but new research with data from 18 countries suggests that older people who struggle with loneliness - rather than strictly being alone - may experience a faster mental and physical decline.

16 Jun 2026

NHS dental costs will hit £5.3 billion as older adults carry the burden

A UK cost-of-illness projection estimates that direct NHS dental treatment costs for adult caries and periodontal disease will rise by 20%, from £4.42 billion in 2020 to £5.30 billion by 2050. The burden shifts strongly toward older adults and severe disease, supporting prevention and earlier intervention as NHS dental planning priorities.

15 Jun 2026

Study investigates whether obesity accelerates brain aging

Scientists have long known that being obese increases the risk of dementia and Alzheimer's disease. What remains unclear is how that risk develops in the brain.

15 Jun 2026

Blood-based indicator assesses organ age to predict disease risk

The candles on your birthday cake don't tell the whole story. As anyone who ever attended a high-school reunion can tell you, some people age faster than others.

15 Jun 2026

Research links low-energy falls to triage undertreatment in female brain injuries

Female patients with traumatic brain injury (TBI) are 26% less likely to be admitted to a specialized trauma center than males, according to a study on data from Ontario published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251721. This difference persisted even after the researchers accounted for factors such as age, severity of injury, other health conditions, and socioeconomic circumstances.

15 Jun 2026

Lab trials prove copper therapy enhances cognitive function and spatial learning

Monash University researchers have found in laboratory experiments that a drug which delivers copper to the brain significantly reduces toxic Alzheimer's proteins and improves long-term spatial memory.

15 Jun 2026

Glucosamine may worsen Alzheimer’s by fueling abnormal brain glycosylation

A Nature Metabolism study identifies brain hyperglycosylation as a metabolic driver of Alzheimer’s disease, with increased N-glycan biosynthesis seen in human AD tissue and mouse models. Reducing glycosylation improved memory in AD mice, while glucosamine worsened memory deficits in 5xFAD mice and was associated with poorer outcomes in dementia patients.

14 Jun 2026

ChatGPT fills gaps like a confabulator, not a hallucinating mind

A Perspective article argues that large language model errors more closely resemble confabulations, while speech recognition errors, such as unsupported Whisper transcriptions, are functionally closer to hallucinations. The authors stress that these parallels are behavioral and provisional, not evidence of shared consciousness, and suggest that psychiatric concepts could help improve AI reliability.

11 Jun 2026